应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01952 云顶新耀
休市中 06-12 16:08:21
27.700
+0.300
+1.09%
最高
28.180
最低
27.020
成交量
459.58万
今开
27.500
昨收
27.400
日振幅
4.23%
总市值
98.06亿
流通市值
98.06亿
总股本
3.54亿
成交额
1.27亿
换手率
1.30%
流通股本
3.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
交银国际：维持云顶新耀(01952)买入评级 海外开发前景可期
智通财经 · 06-10
交银国际：维持云顶新耀(01952)买入评级 海外开发前景可期
云顶新耀公告：CBC集团于6月8日至9日斥资1890万港元购入67.9万股
投资观察 · 06-10
云顶新耀公告：CBC集团于6月8日至9日斥资1890万港元购入67.9万股
【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指BD合作密集落地
金吾财讯 · 06-10
【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指BD合作密集落地
港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%
金吾财讯 · 06-10
港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%
中金：维持云顶新耀(01952)跑赢行业评级 目标价41.5港元
智通财经 · 06-10
中金：维持云顶新耀(01952)跑赢行业评级 目标价41.5港元
云顶新耀(01952)获主要股东傅唯增持67.9万股
智通财经 · 06-10
云顶新耀(01952)获主要股东傅唯增持67.9万股
CBC集团斥资1890万港元，以每股27.9港元增持云顶新耀67.9万股
美股速递 · 06-10
CBC集团斥资1890万港元，以每股27.9港元增持云顶新耀67.9万股
云顶新耀切入老花眼消费医疗，收购LNZ100大中华区开发及商业化权益 | 长三角资本局
长三角资本局 · 06-09
云顶新耀切入老花眼消费医疗，收购LNZ100大中华区开发及商业化权益 | 长三角资本局
云顶新耀获董事会主席吴以芳增持2万股 每股作价28.8港元
新浪港股 · 06-08
云顶新耀获董事会主席吴以芳增持2万股 每股作价28.8港元
云顶新耀(01952)与箕星订立在大中华区开发及商业化LNZ100的协议
智通财经 · 06-08
云顶新耀(01952)与箕星订立在大中华区开发及商业化LNZ100的协议
董事会主席吴以芳增持云顶新耀(01952)2万股 每股作价28.8港元
智通财经 · 06-05
董事会主席吴以芳增持云顶新耀(01952)2万股 每股作价28.8港元
【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指肾科潜在重磅单品成功BD出海
金吾财讯 · 06-04
【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指肾科潜在重磅单品成功BD出海
CBC集团斥资2000万港元购入云顶新耀69万股股份
投资观察 · 06-04
CBC集团斥资2000万港元购入云顶新耀69万股股份
云顶新耀(01952)获公司主要股东增持69万股
智通财经网 · 06-04
云顶新耀(01952)获公司主要股东增持69万股
CBC集团以每股28.93港元购入69万股云顶新耀股份，涉资约2000万港元
美股速递 · 06-04
CBC集团以每股28.93港元购入69万股云顶新耀股份，涉资约2000万港元
云顶新耀发布2026年5月股份变动月报表，新增112,601股
公告速递 · 06-03
云顶新耀发布2026年5月股份变动月报表，新增112,601股
先买后卖 云顶新耀一笔授权交易首付款赚了8倍多
第一财经 · 06-03
先买后卖 云顶新耀一笔授权交易首付款赚了8倍多
港股异动 | 云顶新耀(01952)高开近5% 向Travere授予独家授权以开发和商业化civorebrutinib
智通财经 · 06-03
港股异动 | 云顶新耀(01952)高开近5% 向Travere授予独家授权以开发和商业化civorebrutinib
云顶新耀授予董事股份购回授权，规模达已发行股本一成
公告速递 · 06-02
云顶新耀授予董事股份购回授权，规模达已发行股本一成
云顶新耀：附属公司与Travere签署独家合作协议 预计获1.13亿美元前期付款
财中社 · 06-02
云顶新耀：附属公司与Travere签署独家合作协议 预计获1.13亿美元前期付款
公司概况
公司名称：
云顶新耀
所属市场：
SEHK
上市日期：
--
主营业务：
云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"云顶新耀","latestPrice":27.7,"timestamp":1781251701006,"preClose":27.4,"halted":0,"volume":4595807,"delay":0,"changeRate":0.010948905109489078,"floatShares":354000000,"shares":354000000,"eps":-1.031100027426243,"marketStatus":"休市中","change":0.3,"latestTime":"06-12 16:08:21","open":27.5,"high":28.18,"low":27.02,"amount":127200454,"amplitude":0.042336,"askPrice":27.72,"askSize":3500,"bidPrice":27.7,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-1.0797586804059083,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":7,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":27.4,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":1.4661842433451484,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952/wiki","defaultTab":"wiki","newsList":[{"id":"2642448900","title":"交银国际：维持云顶新耀(01952)买入评级 海外开发前景可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2642448900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642448900?lang=zh_cn&edition=full","pubTime":"2026-06-10 13:45","pubTimestamp":1781070322,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，云顶新耀与多家中国内地药企达成授权许可/资产收购协议，引进多款自免/肾科、心血管、眼科领域重磅单品。该行看好EVER001的海外市场容量和适应症开发前景、以及中国内地商业化产品组合和平台的扩张潜力，维持买入评级。EVER001膜性肾病疗效数据优异，海外开发有望提速公司近期将EVER001的海外权益首予Travere Therapeutics。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188750965","title":"云顶新耀公告：CBC集团于6月8日至9日斥资1890万港元购入67.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1188750965","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188750965?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:45","pubTimestamp":1781055934,"startTime":"0","endTime":"0","summary":"云顶新耀有限公司（股票代码：1952.HK）近日发布公告披露，CBC集团于2026年6月8日至9日期间，在公开市场购入公司股份67.9万股，总交易金额约为1890万港元，每股平均作价为27.9港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642941943","title":"【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指BD合作密集落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2642941943","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642941943?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:39","pubTimestamp":1781055568,"startTime":"0","endTime":"0","summary":"倍捷欣已于中国内地获批用于NMOSD，另有膜性肾病处于优先审评阶段。LNZ100 为治疗老视的滴眼液，已在美国获批、并在中国内地递交上市申请，预计1Q27获批。公司近期将EVER001的海外权益首予Travere Therapeutics。该机构看好EVER001的海外市场容量和适应症开发前景、以及中国内地商业化产品组合和平台的扩张潜力，维持买入评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642419555","title":"港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642419555","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642419555?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:26","pubTimestamp":1781054819,"startTime":"0","endTime":"0","summary":"腾讯控股高开0.35%，公司宣布，公司对24.5亿美元及150亿元人民币票据进行定价。当中，10年期和20年期美元票据的本金额，分别为17.5亿美元及7亿美元，利率分别为5%及5.6%，发售价分别占本金额的99.689%及99.571%；10年期和30年期人民币票据的本金额，分别为110亿及40亿元人民币，利率分别为2.5%及3.1%，发售价分别占本金额的100%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"891af32a1eeea07164010ec7353ceace","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983427","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0431992006.USD","LU0128525689.USD","LU0348816934.USD","LU1267930227.SGD","LU2226246903.HKD","HK0000306685.HKD","02800","LU2187417386.USD","LU2293587155.HKD","LU0823041008.USD","BK1240","LU1226288170.HKD","BK1190","07300","82800","LU0235996351.USD","LU0106959298.USD","LU1051769294.HKD","LU2148510915.USD","LU2251237306.USD","LU0061477393.USD","LU0106252389.USD","IE00B3M56506.USD","03088","SG9999014005.SGD","LU0823040885.USD","LU0543330566.HKD","LU1323998911.USD","LU0320764599.SGD","IE00BZ08YT58.USD","SGXZ99366536.SGD","LU0359201885.HKD","LU0877626530.USD","LU0164865239.USD","LU1188198961.HKD","LU1956131251.USD","LU0577902298.EUR","HSBA.UK","513600","LU0329678170.USD","LU0531971595.HKD","LU2279701549.SGD","LU1102505762.USD","LU0096374516.USD","80175","LU0878005551.USD","LU2348774022.SGD","BK1555","IE00BGV7N243.SGD","LU0196878994.USD","LU1044876610.USD","SG9999015986.USD","IE00BF5LJ272.USD","LU0128522157.USD","LU0455707207.USD","LU2929501877.USD","LU0289961442.SGD","LU1623119135.USD","BK1191","LU1785774172.SGD","LU0821914370.USD","LU0797268264.HKD","LU1951186391.HKD","LU2271345857.HKD","LU0608807433.USD","00005","LU0594300179.USD","LU0634319403.HKD","LU0868486357.SGD","HK0000306701.USD","03033","LU2125910500.SGD","SG9999002562.SGD","LU0169518387.USD","LU0516423174.USD","IE00B031HY20.USD","BK1502","LU2362541513.USD","LU1282651121.HKD","IE00BZ08YR35.GBP","LU2237443895.HKD","SG9999007991.SGD","GELYY","LU0540923850.HKD","KSTmain","LU2778985437.USD","LU1917777945.USD","LU0588546209.SGD","00175","LU0890818403.SGD","LU0880133367.SGD","BK1615","LU0642271901.SGD","LU0488056044.USD","LU0557290698.USD","TCEHY","09999","IE0004086264.USD","LU0823397103.USD","LU0320764243.SGD","LU0979878070.USD","LU1102505929.USD","IE00BFXG0V08.USD","SG9999002828.SGD","LU0651947912.USD","LU0675040207.SGD","LU2251237488.HKD","LU0048575426.USD","SG9999015945.SGD","IE0032834883.USD","LU2476274308.USD","IE0003795394.USD","LU0326948709.USD","07500","LU0819121731.USD","BK1576","IE0032431581.USD","LU0070217475.USD","LU0348827113.USD","LU1770036033.HKD","SG9999001069.SGD","LU1105468828.SGD","LU0254981946.USD","LU0264606111.USD","SG9999000459.SGD","LU2351347302.SGD","07200","LU0414403682.SGD","LU2177674079.SGD","LU0067412154.USD","LU0886674414.USD","LU2008162690.USD","LU0203347892.USD","LU0251144936.SGD","LU2097828474.EUR","LU0348788117.USD","LU0329678337.USD","LU0648948544.HKD","LU0048580855.USD","LU0203345920.USD","LU0039217434.USD","LU1481107354.HKD","IE00B067MR52.USD","03993","LU0054450605.USD","LU2237443382.USD","LU0143863784.USD","LU2237443978.SGD","LU0828237940.HKD","HK0000151867.HKD","LU0650527681.SGD","LU0049112450.USD","LU0052750758.USD","LU0348723411.USD","01024","LU1051768304.USD","LU0871576103.HKD","HK0000914660.USD","LU0345776255.USD","LU0499858602.USD","LU0955669360.SGD","LU0509642566.USD","LU0043850808.USD","LU1316542783.SGD","SG9999014898.SGD","LU2097828805.USD","LU1810669033.SGD","LU0259732245.USD","BK1531","LU0244354667.USD","LU0511384066.AUD","HK0000320264.USD","LU0327786744.USD","LU0918141705.HKD","LU2087589342.USD","LU0608807946.USD","LU2213484517.USD","LU1211504680.USD","GB00BDT5M118.USD","LU1202635105.USD","LU2498475776.HKD","IE0004091025.USD","LU1883866441.USD","LU1861219969.SGD","HK0000914686.HKD","LU0577902538.SGD","LU0472753341.HKD","LU0164880469.USD","LU0163747925.USD","BK1517","HK0000288784.HKD","LU0211331839.USD","LU1044875133.USD","LU0577902611.USD","SG9999001846.SGD","BK1574","LU1251922891.USD","LU0828238088.HKD","SG9999014914.USD","LU1868837722.USD","LU0345775950.USD","LU0417516902.SGD","IE00BQXX3F31.USD","07226","LU0499858438.USD","LU0607220059.USD","LU2294711473.HKD","LU1224709979.USD","BK1608","LU2023250504.SGD","03115","LU0149721374.USD","LU0348783233.USD","LU2247934214.USD","SG9999000327.SGD","LU2265009873.SGD","LU1861214812.USD","BK1586","BK1095","81299","LU0047713382.USD","SG9999004311.SGD","BK1539","LU0516422952.EUR","00960","IE0008368742.USD","LU1734074674.USD","SGXZ31699556.SGD","BK1592","LU0080751232.USD","LU0823413660.USD","LU0210533765.USD","IE00BQXX3D17.EUR","LU0158827948.USD","IE00B3T34201.USD","LU2153591404.USD","LU1046422090.SGD","LU1282648689.USD","HHImain","LU0106259558.USD","LU0165289439.USD","LU1725190679.HKD","HSI","603993","LU0396098781.USD","LU0572940350.SGD","BK1227","02837","IE0031814852.USD","IE00B29SXG58.USD","LU0708995153.HKD","LU1718418525.SGD","LU0289960550.SGD","BK1588","LNVGY","LU0231483743.USD","LU1226287792.SGD","LU0251143458.SGD","LU0049853897.USD","SG9999000418.SGD","LU0630378692.HKD","IE0008368411.USD","LU0708995583.HKD","LU0072913022.USD","03032","LU1196710864.SGD","LU1515016050.SGD","BK1141","IE0009570106.USD","LU0069063385.USD","03419","LU0918141887.USD","LU1568876335.HKD","IE00B0JY6N72.USD","LU0541501648.USD","LU0516422440.USD","BK1609","LU0158827781.USD","LU0348783662.USD","LU0192582467.USD","TCHmain","LU1481012133.USD","LU2153592121.USD","HK0001040168.HKD","HSTECH","LU1400636491.USD","LU0633140560.USD","BK1575","LU0456842615.SGD","LU0823039010.USD","LU1048484197.HKD","SG9999001226.SGD","BK1572","SG9999001051.SGD","LU0188438112.USD","00700","LU0862451753.SGD","LU0348784397.USD","LU0784639295.USD","SGXZ90724238.SGD","SG9999017495.SGD","LU2360107325.USD","83115","IE00B8L5B284.USD","LU0048388663.USD","LU2111349929.HKD","09088","BK1526","IE00BYQQ9H92.USD","03143","LU0197773160.USD","LU0516423091.SGD","LU0310800965.SGD","LU1196710195.USD","LU1983260115.SGD","LU0502904849.HKD","SG9999014013.SGD","LU0057025933.USD","LU0228659784.USD","LU0128522744.USD","LU0173614495.USD","LU1152091168.USD","LU0359202008.SGD","LU0541502299.USD","LU0072462343.USD","LU2462611646.USD","LU0287142896.SGD","LU0314109678.HKD","LU2028103732.USD","LU1813983027.USD","LU1720050803.USD","LU0315179316.USD","LU0205439572.USD","LU1282649141.HKD","LU1366334578.USD","HTCD.SI","LU1770034418.SGD","HK0000352382.USD","SG9999018865.SGD","LU0315178854.USD","LU2152927971.USD","80992","LU0594300419.USD","LU1981816686.USD","IE00BZ08YS42.EUR","LU0463099449.HKD","HK0000352291.HKD","LU0823413587.USD","LU1064131003.USD","LU1152091754.HKD","LU2125910849.SGD","LU0417516571.SGD","BK1544","SG9999001093.SGD","LU1814569148.SGD","LU1880383366.USD","SG9999014674.SGD","LU0449515922.USD","LU2051468812.USD","LU0348814723.USD","LU0831093199.SGD","LU1048588211.SGD","LU1961090484.USD","LU1119993845.HKD","LU1670756490.USD","LU0862451837.USD","LU0878004406.USD","SG9999001689.USD","LU0738912210.USD","LU0819123356.HKD","LU0700851271.USD","IE0003895053.USD","SG9999006597.SGD","LU0823426480.USD","LU0972618739.USD","LU0229945570.USD","LU0384037296.USD","SG9999013353.USD","LU0345769631.USD","LU1282649810.SGD","03067","03692","LU1400636657.SGD","LU0348767384.USD","LU1226287875.USD","07552","HK0000288743.USD","LU1130305938.SGD","LU0214875030.USD","LU2089283258.USD","LU0328353924.USD","IE00B97KM107.HKD","LU1568876251.USD","SG9999004303.SGD","03417","LU0348805143.USD","LU1808992512.USD","BK1618","LU1242518931.SGD","SG9999014880.SGD","LU0516422366.SGD","LU0449509016.USD","LU0326950275.SGD","LU1363072403.SGD","LU1226287529.USD","LU1868838027.USD","LU2237443622.USD","LU2257852520.SGD","LU1831875114.USD","LU0048597586.USD","LU1993786604.SGD","SG9999018857.SGD","LU2242644610.SGD","LU1769817179.HKD","LU2362540622.SGD","LU0605514214.HKD","LU0762540952.USD","LU2045819591.USD","SG9999014906.USD","LU1733274473.HKD","LU1691799644.USD","LU1400636574.HKD","LU2106854487.HKD","LU0593848301.USD","LU0117844026.USD","LU0210526637.USD","LU0261950983.USD","LU0011963245.USD","LU1064130708.USD","LU1675838814.USD","LU0630378429.USD","LU0456846285.SGD","LU1642822792.SGD","LU0651946864.USD","LU1868837565.USD","LU0348735423.USD","BK1591","NTES","LU0293314216.USD","AAGIY","LU1196710351.USD","LU1769817096.USD","SG9999003461.SGD","BK1583","LU0823397285.USD","LU0289739343.SGD","LU0084288322.USD","LU0441854154.USD","LU1712237335.SGD","BK1589","IE00B031HW06.USD","LU2097828557.USD","LU1960683339.HKD","LU1719994722.HKD","IE00BKZH1Z71.USD","LU0197773673.USD","LU1804176565.USD","LU2399975544.HKD","LU0269904917.USD","LU0469268626.HKD","LU2089284900.SGD","BK1590","LU1044874839.SGD","LGFRY","LU0211977185.USD","LU0261947096.USD","LU1282651048.USD","IE00B5MMRT66.SGD","LU0831103253.SGD","LU1880383440.USD","LU2348773727.SGD","LU2476274720.SGD","LU0029874905.USD","MCHmain","LU0127658192.USD","LU0266013472.USD","LU2237443549.SGD","SGXZ23171101.USD","LU0345769128.USD","SG9999002463.SGD","LU2039709279.SGD","LU0672654166.SGD","LU0320764755.SGD","LU0640798160.USD","LU2097828714.EUR","LU2237443465.HKD","LU0791591158.USD","LU2449936058.SGD","LU0417516738.SGD","LU0228367735.SGD","LU0181495838.USD","LU1235295612.USD","IE00BPRC5H50.USD","06181","LU0882747503.HKD","LU0955648018.USD","LU1688375341.USD","LU0143863198.USD","09067","81024","LU0149534421.HKD","LU0898667661.SGD","SG9999004220.SGD","LU0370786039.SGD","LU0611395673.USD","LU1439103000.SGD","LU1645745479.HKD","SG9999015978.USD","BK1516","LU0589944569.HKD","LU2133065610.SGD","HSBC","LU0261950470.USD","LU1303224171.USD","LU0737861699.HKD","LU0051755006.USD","LU0561508036.HKD","LU0828237510.HKD","LU1366334651.USD","LU1282649067.USD","SG9999001903.USD","LU0175139822.USD","LU0132412106.USD","LU0856984785.SGD","LU0588545904.SGD","LU2362541273.HKD","LU0577902371.SGD","IE00B5TLWC47.USD","IE00B543WZ88.USD","LU0683595622.HKD","03423","SG9999014039.USD","IE00B0169N27.USD","LU0140636845.USD","LU0531970944.HKD","EVS.SI","LU0456827905.SGD","LU1629966141.USD","LU0955623706.USD","LU0823038988.USD","02833","LU1821325948.USD","LU0164872284.USD","LU0823426308.USD","09115","LU0873338254.USD","LU2023251221.USD","IE00BQXX3C00.GBP","SG9999014021.USD","LU0029875118.USD","BK1161","LU0865486749.SGD","IE00B031J352.USD","IE0034224299.USD","LU0633140727.USD","LU1008478684.HKD","HSHD.SI","LU1974910355.USD","LU1328615791.USD","LU0348766576.USD","LU1733274390.USD","LU0786609619.USD","LU0210527791.USD","LU1439102457.SGD","LU0117841782.USD","00992","BK1119","LU0577902454.USD","LU1504937902.USD","LU0762541174.USD","IE00B8HQ1Z84.USD","LU0588545490.SGD","LU1023057109.AUD","LU1655091459.SGD","LU0791590937.USD","BK1594","LU0307460666.USD","BK1184","LU0543330483.HKD","LU1226288253.USD","01952","BK1521","BK1610","WXXWY","LU0054237671.USD","LU0971096721.USD","BK1607","BK1231","SG9999006514.SGD","LU0501845795.SGD","BK1601","LU0762542818.HKD","LU1048596156.SGD","LU0572939691.SGD","IE0003851619.USD","LU1115378108.SGD","IE0001KFT4U8.USD","LU0107464264.USD","LU0052756011.USD","LU1807302812.USD","SG9999015952.SGD","LU1242518857.USD","LU1226288097.SGD","LU2097828631.EUR","LU0588545730.USD","LU0572944931.SGD","LU0737861772.HKD","LU0359201612.USD","LU0985320562.USD","LU1224444064.USD","IE0008369823.USD","01299","HK0001040143.USD","LU3063872942.SGD","SGXZ51526630.SGD","BK1193","LU1328277881.USD","03037","HK0000320223.HKD","IE00B0169L03.USD","LU1794554557.SGD","LU0348825331.USD","02269","BK1104","LU2317271919.USD","SGXZ81514606.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642416083","title":"中金：维持云顶新耀(01952)跑赢行业评级 目标价41.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642416083","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642416083?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:12","pubTimestamp":1781053978,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持云顶新耀2026年和2027年盈利预测不变。基于DCF，予跑赢行业评级与目标价41.5港元，较当前股价有48.43%上行空间。该行认为该合作将加速EVER001的全球临床开发和商业化进程，特别是在膜性肾病的开发进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642413615","title":"云顶新耀(01952)获主要股东傅唯增持67.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642413615","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642413615?lang=zh_cn&edition=full","pubTime":"2026-06-10 07:10","pubTimestamp":1781046622,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀(01952)发布公告，公司董事会获非执行董事、董事会荣誉主席兼本公司主要股东傅唯先生(傅先生)告知，自2026年6月8日至2026年6月9日期间，康桥资本(作为本公司主要股东)于市场购入67.9万股本公司普通股(股份)，总代价约为1890万港元，平均价格约为每股股份27.90港元。据傅先生及康桥资本表示，其透过场内收购方式购入股份，乃基于其对本公司未来前景及长远发展的坚定信心。在遵守适用法律及法规的前提下，傅先生及康桥资本不排除在适当时候进一步增持其于本公司股份的可能性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1574","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136508379","title":"CBC集团斥资1890万港元，以每股27.9港元增持云顶新耀67.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1136508379","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136508379?lang=zh_cn&edition=full","pubTime":"2026-06-10 07:02","pubTimestamp":1781046176,"startTime":"0","endTime":"0","summary":"根据市场披露文件，CBC集团于2026年6月8日至9日期间，在公开市场以每股27.9港元的价格，购入了云顶新耀共计67.9万股普通股。此次交易总金额约为1890万港元，显示出该投资机构对云顶新耀的持续信心与布局。此次增持行动发生在近期市场波动之际，CBC集团选择在此节点进行大额买入，可能被市场解读为对其长期价值的认可。市场分析指出，机构投资者的增持行为往往能传递积极信号，尤其在当前复杂的市场环境中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","01952","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642493523","title":"云顶新耀切入老花眼消费医疗，收购LNZ100大中华区开发及商业化权益 | 长三角资本局","url":"https://stock-news.laohu8.com/highlight/detail?id=2642493523","media":"长三角资本局","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642493523?lang=zh_cn&edition=full","pubTime":"2026-06-09 21:44","pubTimestamp":1781012640,"startTime":"0","endTime":"0","summary":" 靠耐赋康实现收入放量后，云顶新耀开始把商业化触角伸向老花眼。 6月8日，云顶新耀宣布与箕星药业达成资产收购协议，取得老视滴眼液LNZ100在中国内地、香港、澳门及台湾地区的开发、生产和商业化权益。双方未披露交易金额。根据协议，云顶新耀将向箕星药业支付首付款及开发里程碑付款，并承接箕星药业此前许可协议项下的相关权利与义务。 云顶新耀接手的，是一款已经完成中国关键临床、距离商业化只剩监管审评环节的产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-06-09/doc-iniavmyp4993677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891","01952","BK1161","BK1583","399355","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641171090","title":"云顶新耀获董事会主席吴以芳增持2万股 每股作价28.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641171090","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641171090?lang=zh_cn&edition=full","pubTime":"2026-06-08 07:58","pubTimestamp":1780876680,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，6月4日，董事会主席吴以芳增持云顶新耀（01952）2万股，每股作价28.8港元，总金额为57.6万港元。增持后最新持股数目约为216.02万股，最新持股比例为0.61%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-08/doc-iniarzfy7258720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1161","EWH","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116171","title":"云顶新耀(01952)与箕星订立在大中华区开发及商业化LNZ100的协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116171","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116171?lang=zh_cn&edition=full","pubTime":"2026-06-08 06:59","pubTimestamp":1780873199,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀 发布公告，于2026年6月5日，本公司与箕星药业有限公司(箕星)的全资附属公司箕星药业香港有限公司订立协议(该协议)，箕星药业香港有限公司不可撤销地向本公司授予一项独家许可，以在大中华区开发、生产及商业化LNZ100。在中国，LNZ100的新药上市申请已于2025年9月提交，预计将于2027年第一季度获得批准。该疗法有潜力解决中国巨大的未满足医疗需求，并将自身定位为老花眼治疗的同类最佳无创治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云顶新耀(01952)与箕星订立在大中华区开发及商业化LNZ100的协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01952","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641214854","title":"董事会主席吴以芳增持云顶新耀(01952)2万股 每股作价28.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641214854","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641214854?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:20","pubTimestamp":1780662037,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月4日，董事会主席吴以芳增持云顶新耀(01952)2万股，每股作价28.8港元，总金额为57.6万港元。增持后最新持股数目约为216.02万股，最新持股比例为0.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01952","BK1161","BK1574","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640363691","title":"【券商聚焦】交银国际维持云顶新耀(01952)买入评级 指肾科潜在重磅单品成功BD出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2640363691","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640363691?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:20","pubTimestamp":1780539615,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，云顶新耀 近日宣布与Travere Therapeutics达成许可合作协议，将EVER001的全球权益首予后者，并将获得1.125亿美元首付款、最高10.3亿美元的里程碑付款及高单位数至双位数百分比的销售分成。Travere是一家专注于肾病领域的生物制药公司，其核心产品FILSPARI已在美国、欧洲等多个市场获批上市。该机构认为，FILSPARI的成功开发及上市充分体现Travere在肾病领域的深厚专业经验及临床研发、监管事务与商业化能力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983013","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143732465","title":"CBC集团斥资2000万港元购入云顶新耀69万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1143732465","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143732465?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:37","pubTimestamp":1780529854,"startTime":"0","endTime":"0","summary":"6月4日（路透社）—— 云顶新耀有限公司宣布，CBC集团以每股28.93港元的价格，购入该公司69万股股份，总交易金额达2000万港元。\n此次交易进一步凸显了投资者对云顶新耀的关注与信心。每股价格明确为28.93港元，为市场提供了清晰的参考信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187727","title":"云顶新耀(01952)获公司主要股东增持69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187727","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640187727?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:05","pubTimestamp":1780527923,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀 发布公告，公司董事会获非执行董事、董事会荣誉主席兼公司主要股东傅唯先生告知，于2026年6月3日，康桥资本于市场购入69万股公司普通股，总代价约为2000万港元，平均价格约为每股股份28.93港元。据傅唯先生及康桥资本表示，其透过场内收购方式购入股份，乃基于其对公司未来前景及长远发展的坚定信心。在遵守适用法律及法规的前提下，傅唯先生及康桥资本不排除在适当时候进一步增持其于公司股份的可能性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云顶新耀(01952)获公司主要股东增持69万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK1574","01952","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183580193","title":"CBC集团以每股28.93港元购入69万股云顶新耀股份，涉资约2000万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183580193","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183580193?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:03","pubTimestamp":1780527794,"startTime":"0","endTime":"0","summary":"CBC集团近日完成一笔对云顶新耀（01952.HK）的股份收购，以每股28.93港元的价格购入69万股，总交易金额约为2000万港元。此次交易显示出市场对云顶新耀的关注与投资信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116117432","title":"云顶新耀发布2026年5月股份变动月报表，新增112,601股","url":"https://stock-news.laohu8.com/highlight/detail?id=1116117432","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116117432?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:22","pubTimestamp":1780485740,"startTime":"0","endTime":"0","summary":"云顶新耀有限公司于2026年6月3日发布截至2026年5月31日止的股份变动月报表，披露截至报告期末公司普通股与注册资本等情况。根据公告，公司法定/注册股本维持为500,000,000股，对应注册股本为USD 50,000，与上月一致，未发生变化。公司确认其公众持股量已达上市规则要求。库存股份数量保持为零，未见回购或注销新增情况。公司方面确认了所有增发及股权激励授予均符合香港联交所《上市规则》和相关法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640756219","title":"先买后卖 云顶新耀一笔授权交易首付款赚了8倍多","url":"https://stock-news.laohu8.com/highlight/detail?id=2640756219","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640756219?lang=zh_cn&edition=full","pubTime":"2026-06-03 13:14","pubTimestamp":1780463643,"startTime":"0","endTime":"0","summary":"【先买后卖 云顶新耀一笔授权交易首付款赚了8倍多】中国本土药企的对外授权交易热潮持续。6月1日晚间，云顶新耀（01952.HK）宣布与纳斯达克企业Travere Therapeutics达成独家授权许可与合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033758819289.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033758819289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1161","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640792739","title":"港股异动 | 云顶新耀(01952)高开近5% 向Travere授予独家授权以开发和商业化civorebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2640792739","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640792739?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:25","pubTimestamp":1780449927,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀高开近5%，截至发稿，涨4.71%，报31.12港元，成交额227.18万港元。消息面上，云顶新耀发布公告，于2026年6月2日，公司全资附属公司Everest Medicines Pte.Ltd.(授权人)与Travere Therapeutics,Inc.订立独家许可与合作协议，据此，授权人将向Travere授予一项独家、全球性的授权，以开发及商业化civorebrutinib。交割将于满足特定先决条件及监管程序后发生，授权人最终达成的里程碑付款金额仍存在不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK4588","BK1583","BK1574","BK4585","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173973650","title":"云顶新耀授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1173973650","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173973650?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:17","pubTimestamp":1780409824,"startTime":"0","endTime":"0","summary":"云顶新耀发布公告，将于2026年6月26日（星期五）上午9时30分召开股东周年大会，通过虚拟会议形式审议并批准一项股份购回授权。该授权如获股东大会通过，董事会可于适用法律及公司组织章程规定的期限内，回购最多相当于公司于股东大会当日已发行股本10%的股份。若获全面行使，此次购回授权的最高规模合计达35,379,997股。根据董事会安排，为确定股东有权出席并投票的资格，公司将于2026年6月23日至2026年6月26日暂停办理股份过户登记。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"云顶新耀授予董事股份购回授权，规模达已发行股本一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640594822","title":"云顶新耀：附属公司与Travere签署独家合作协议 预计获1.13亿美元前期付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2640594822","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640594822?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:10","pubTimestamp":1780402200,"startTime":"0","endTime":"0","summary":"6月2日，云顶新耀（01952）发布公告，本公司全资附属公司EverestMedicines(Singapore)Pte.Ltd.（授权人）与TravereTherapeutics,Inc.（Travere）（纳斯达克全球市场上市公司，股份代号为TVTX）订立独家许可与合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023757752413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","BK1583","01952"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.0369},{"period":"1month","weight":-0.0894},{"period":"3month","weight":-0.2327},{"period":"6month","weight":-0.3822},{"period":"1year","weight":-0.517},{"period":"ytd","weight":-0.2509}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0294},{"period":"6month","weight":-0.0485},{"period":"1year","weight":0.0284},{"period":"ytd","weight":-0.0356}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01035},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039331},{"month":3,"riseRate":0.333333,"avgChangeRate":0.002002},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.092533},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.045773},{"month":6,"riseRate":0.666667,"avgChangeRate":0.242409},{"month":7,"riseRate":0.2,"avgChangeRate":-0.114966},{"month":8,"riseRate":0.2,"avgChangeRate":-0.112869},{"month":9,"riseRate":0.6,"avgChangeRate":0.046163},{"month":10,"riseRate":0.4,"avgChangeRate":-0.024036},{"month":11,"riseRate":0.5,"avgChangeRate":0.086142},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131823}],"exchange":"SEHK","name":"云顶新耀","nameEN":"EVEREST MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云顶新耀,01952,云顶新耀股票,云顶新耀股票老虎,云顶新耀股票老虎国际,云顶新耀行情,云顶新耀股票行情,云顶新耀股价,云顶新耀股市,云顶新耀股票价格,云顶新耀股票交易,云顶新耀股票购买,云顶新耀股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}